Context: Analyses released in September 2026 showed that India published about 1.6 million Scopus-indexed papers between 2020 and 2025 — third in the world by volume — but ranked only 19th in aggregate h-index. University patent grants fell sharply, very few granted patents were commercialised, and retractions have risen.
Key Numbers
- Aggregate h-index: about 925, compared with about 3,213 for the US.
- University patent grants fell 67% in 2024-25; the grant rate for university applications is about 3%, against a national average of about 24%.
- The share of granted patents in commercial use fell from 12.1% (2022-23) to 1.6% (2024-25).
- India ranks third in paper retractions; the retraction rate rose from about 1.5 to 3.5 per 1,000 papers between 2012 and 2022.
Why Volume Is Not Translating into Impact
- Incentives based on publication counts (for hiring and promotion) encourage quantity over quality; predatory journals and paper mills.
- Low and fragmented funding: gross expenditure on R&D (GERD) of about 0.65% of GDP, against 2-3% in China, the US and South Korea; private-sector share is only about 36%.
- Weak links between universities and industry; few technology transfer offices.
- Limited research capacity outside the IITs, IISc and a few institutes.
Policy Responses
- Anusandhan National Research Foundation (ANRF), created by the ANRF Act, 2023, to fund and coordinate research — chaired by the Prime Minister.
- Research, Development and Innovation (RDI) Scheme (2025): a ₹1 lakh crore fund for long-term, low-cost financing of private R&D.
- One Nation One Subscription (2025): national access to about 13,000 journals for public institutions.
- UGC rules on research integrity; the Plagiarism Regulations (2018).
Static GK Connect
- h-index: the largest number h such that h papers have each been cited at least h times — combines productivity and impact.
- Global Innovation Index (WIPO): India ranked 38th in 2025 (39th in 2024).
- Indian Patent Office functions under the Controller General of Patents, Designs and Trade Marks (DPIIT). Patent term: 20 years.
- Section 3(d) of the Patents Act, 1970 bars patents on new forms of known substances without enhanced efficacy (upheld in Novartis v. Union of India, 2013).
Exam Angle — Prelims & Mains
- UPSC PYQ Link (Mains 2024, GS Paper 3): "What is the present world scenario of intellectual property rights with respect to life materials? Although India is second in the world to file patents, still only a few have been commercialized. Explain the reasons behind this less commercialization."
- Practice Mains Question (GS Paper 3, 15 marks, 250 words): India's research output is growing faster than its research impact. Analyse the reasons and assess the role of the Anusandhan National Research Foundation.
- Practice Prelims MCQ: With reference to research and innovation in India, consider the following statements:1. The Anusandhan National Research Foundation was established by an Act of Parliament.2. The term of a patent in India is 20 years.3. India's gross expenditure on R&D exceeds 2% of its GDP.Which of the statements given above is/are correct?(A) 1 and 2 only(B) 2 and 3 only(C) 1 and 3 only(D) 1, 2 and 3
Show answer
Answer: (A) 1 and 2 only — Statement 1 is CORRECT — the ANRF Act, 2023. Statement 2 is CORRECT — Section 53 of the Patents Act gives a 20-year term. Statement 3 is INCORRECT — India's GERD is about 0.65% of GDP.
- Practice Prelims MCQ: With reference to research and innovation in India, consider the following statements: